Amyloid-β may be released from non-junctional varicosities of axons generated from abnormal tau-containing brainstem nuclei in sporadic Alzheimer’s disease: a hypothesis
详细信息 查看全文
- 作者：Heiko Braak (1)
Kelly Del Tredici (1) - 刊名：Acta Neuropathologica
- 出版年：2013
- 出版时间：August 2013
- 年：2013
- 卷：126
- 期：2
- 页码：303-306
- 全文大小：229KB
- 参考文献：1. Agnati LF, Bjelke B, Fuxe K (1995) Volume versus wiring transmission in the brain: a new theoretical frame of neuropsychopharmacology. Med Res Rev 15:33-5 CrossRef
2. Beach TG, Sue LI, Walker DG et al (2012) Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer’s disease: implications for amyloid imaging. J Alzheimers Dis 28:869-76
3. Blennow K, Zetterberg H, Fagan AM (2012) Fluid biomarkers in Alzheimer disease. Cold Spring Harb Perspect Med 2:a006221 CrossRef
4. Braak H, Braak E (1990) Alzheimer’s disease: amyloid deposits and neurofibrillary changes in the striatum. J Neuropathol Exp Neurol 49:215-24 CrossRef
5. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-59 CrossRef
6. Braak H, Del Tredici K (2004) Alzheimer’s disease: intraneuronal alterations precede insoluble amyloid-β formation. Neurobiol Aging 25:713-18 CrossRef
7. Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathol 121:171-81 CrossRef
8. Braak H, Del Tredici K (2012) Where, when, and in what form does sporadic Alzheimer’s disease begin? Curr Opin Neurol 25:708-14 CrossRef
9. Braak H, Braak E, Bohl J et al (1989) Alzheimer’s disease: amyloid plaques in the cerebellum. J Neurol Sci 93:277-87 CrossRef
10. Braak H, Thal DR, Ghebremedhin E et al (2011) Stages of the pathological process in Alzheimer-disease. J Neuropathol Exp Neurol 70:960-69 CrossRef
11. Braak H, Zetterberg H, Del Tredici K, Blennow K (2013) Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid. Acta Neuropathol. doi:10.1007/s00401-013-1139-0
12. Busch C, Bohl J, Ohm TG (1997) Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus. Neurobiol Aging 18:401-06 CrossRef
13. Cohen Z, Molinatti G, Hamel E (1997) Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex. J Cereb Blood Flow Metab 17:894-04 CrossRef
14. Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer’s disease. Acta Neuropathol 118:5-6 CrossRef
15. Elobeid A, Soininen H, Alafuzoff I (2012) Hyperphosphorylated tau in young and middle-aged subjects. Acta Neuropathol 123:97-04 CrossRef
16. German DC, White CL, Sparkman DR (1987) Alzheimer’s disease: neurofibrillary tangles in nuclei that project to the cerebral cortex. Neurosci 21:305-12 CrossRef
17. Goedert M, Klug A, Crowther RA (2006) Tau protein, the paired helical filament and Alzheimer’s disease. J Alzheimers Dis 9(Suppl):195-07
18. Grinberg LT, Rüb U, Ferretti REL et al (2009) The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer’s disease. A precocious onset? Neuropathol Appl Neurobiol 35:406-16 CrossRef
19. Grinberg LT, Korczyn AD, Heinsen H (2012) Cerebral amyloid angiopathy impact on endothelium. Exp Gerontol 47:838-42 CrossRef
20. Grudzien A, Shaw P, Weintraub S et al (2007) Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer’s disease. Neurobiol Aging 28:327-35 CrossRef
21. Grundke-Iqbal I, Iqbal K, Tung Y et al (1986) Abnormal phosphorylation of the microtubule-associated protein / τ (tau) in Alzheimer cytoskeletal pathology. Proc Nat Acad Sci USA 83:4913-917 CrossRef
22. Haass C, Kaether C, Thinakaran G et al (2012) Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2:a006270 CrossRef
23. Haglund M, Sj?beck M, Englund E (2006) Locus ceruleus degeneration is ubiquitous in Alzheimer’s disease: possible implications for diagnosis and treatment. Neuropathology 26:528-32 CrossRef
24. Hyman BT, Phelps CH, Beach TG et al (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement 8:1-3 CrossRef
25. Iqbal K, Grundke-Iqbal I (2008) Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. J Cell Mol Med 12:38-5 CrossRef
26. Iqbal K, Alonso AC, Gong CX et al (1994) Mechanism of neurofibrillary degeneration in Alzheimer’s disease. Mol Neurobiol 9:119-23 CrossRef
27. Iqbal K, Liu F, Gong CX et al (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118:53-9 CrossRef
28. Iseki E, Matsushita M, Kosaka K et al (1989) Distribution and morphology of brain stem plaques in Alzheimer’s disease. Acta Neuropathol 78:131-36 CrossRef
29. Kovács T, Cairns NJ, Lantos PL (1999) β-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer’s disease. Neuropathol Appl Neurobiol 25:481-91 CrossRef
30. Mandelkow EM, Mandelkow E (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2:a006247 CrossRef
31. Mandelkow E, von Bergen M, Biernat J et al (2007) Structural principles of tau and the paired helical filaments of Alzheimer’s disease. Brain Pathol 17:83-0 CrossRef
32. Masters CL, Beyreuther K (2006) Pathways to the discovery of the neuronal origin and proteolytic biogenesis of Aβ amyloid of Alzheimer’s disease. In: Alzheimer: 100?years and beyond. Springer, Berlin, pp 143-49
33. Masters CL, Selkow DJ (2012) Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer’s disease. Cold Spring Harb Perspect Med 2:a006262 CrossRef
34. Mesulam MM, Shaw P, Mash D et al (2004) Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 55:815-28 CrossRef
35. Montine TJ, Phelps CH, Beach TG et al (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123:1-1 CrossRef
36. Nelson PT, Jicha GA, Schmitt FA et al (2007) Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles “do count-when staging disease severity. J Neuropathol Exp Neurol 66:1136-146 CrossRef
37. Nelson PT, Head E, Schmitt FA et al (2011) Alzheimer’s disease is not “brain aging- neuropathological, genetic, and epidemiological human studies. Acta Neuropathol 121:571-87 CrossRef
38. O’Donnell J, Zeppenfeld D, McConnell E et al (2012) Norepinephrine: a neuromodulator that boosts the function of multiple cell types to optimize CNS performance. Neurochem Res 37:2496-512 CrossRef
39. Parvizi J, Van Hoesen GW, Damasio A (2001) The selective vulnerability of brainstem nuclei to Alzheimer’s disease. Ann Neurol 49:53-6 CrossRef
40. Rüb U, Del Tredici K, Schultz C et al (2000) The evolution of Alzheimer’s disease-related cytoskeletal pathology in the human raphe nuclei. Neuropathol Appl Neurobiol 26:553-57 CrossRef
41. Sassin I, Schultz C, Thal DR et al (2000) Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol 100:259-69 CrossRef
42. Sch?nheit B, Zarski R, Ohm TG (2004) Spatial and temporal relationship between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 25:697-11 CrossRef
43. Selkoe DJ (1994) Alzheimer’s disease: a central role for amyloid. J Neuropathol Exp Neurol 53:438-47 CrossRef
44. Serrano-Pozo A, Frosch M, Masliah E et al (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1:a006189 CrossRef
45. Simic G, Stanic G, Mladinov M et al (2009) Does Alzheimer’s disease begin in the brainstem? Neuropathol Appl Neurobiol 35:532-54 CrossRef
46. Thal DR, Rüb U, Schultz C et al (2000) Sequence of Aβ-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59:733-48
47. Thal DR, Rüb U, Orantes M et al (2002) Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791-800 CrossRef
48. Vana L, Kanaan NM, Ugwu IC et al (2011) Progression of tau pathology in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer’s disease. Am J Pathol 179:2533-550 CrossRef
49. Weinshenker D (2008) Functional consequences of locus coeruleus degeneration in Alzheimer’s disease. Curr Alzheimer Res 5:342-45 CrossRef
50. Yamada M, Naiki H (2012) Cerebral amyloid angiopathy. Prog Mol Biol Transl Sci 107:41-8 CrossRef
51. Yoshiyama Y, Lee VMY, Trojanowski JQ (2013) Therapeutic strategies for tau mediated neurodegeneration. J Neurol Neurosurg Psychiatry 84:784-95 CrossRef
52. Zweig RM, Ross CA, Hedreen JC et al (1988) The neuropathology of aminergic nuclei in Alzheimer’s disease. Ann Neurol 24:233-42 CrossRef - 作者单位：Heiko Braak (1)
Kelly Del Tredici (1)
1. Clinical Neuroanatomy Section, Department of Neurology, Center for Biomedical Research, University of Ulm, Helmholtzstrasse 8/1, 89081, Ulm, Germany
文摘